Week one FLT-PET response predicts complete remission to R-CHOP and survival in DLBCL

Despite improved survival in the Rituximab (R) era, a considerable number of patients with diffuse large B-cell lymphoma (DLBCL) ultimately die from the disease. Functional imaging using [(18)F]fluorodeoxyglucose-PET is suggested for assessment of residual viable tumor very early during treatment bu...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Herrmann, Ken, Buck, Andreas K., Schuster, Tibor, Abbrederis, Kathrin, Blümel, Christina, Santi, Ivan, Rudelius, Martina, Wester, Hans-Jürgen, Peschel, Christian, Schwaiger, Markus, Dechow, Tobias, Keller, Ulrich
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2014
Konular:
Clinical Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4147305/
https://ncbi.nlm.nih.gov/pubmed/24979177
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller